[1]Patent:WO2012/20134,2012,A1
[2]ACSChemicalNeuroscience,2019,vol.10,p.3682-3689
[1]Molecules,2019,vol.24
1257855-77-8
1196154-55-8
138350-92-2
149353-95-7
253801-24-0
441065-33-4
879661-41-3 | 2,6-dimethylpiperidine-3-carboxylic acid hydrochloride | AA01C48J | MFCD29991307
1030694-72-4 | 5-[(3-bromophenyl)sulfamoyl]-2-fluorobenzoic acid | AA01C4EG | MFCD10593020
1909319-89-6 | [2-chloro-6-(1H-imidazol-1-yl)phenyl]methanamine dihydrochloride | AA01C4JJ | MFCD29906933
1909319-60-3 | octahydrocyclopenta[b]morpholine-4-carboximidamide hydrochloride | AA01C4OQ | MFCD29906977
1780695-35-3 | 1-cyclobutyl-1H-1,2,3-triazole-4-carboxylic acid | AA01C4T7 | MFCD28518064
1484317-86-3 | 3-methoxy-2,2-dimethylpropane-1-sulfonamide | AA01C4XP | MFCD21122069
2044713-57-5 | 2,3-dibromo-5H,6H,8H-imidazo[2,1-c][1,4]oxazine | AA01C52E | MFCD30476080
1909293-47-5 | rac-(1R,2S)-2-fluorocyclobutane-1-sulfonyl chloride, cis | AA01C56M | MFCD29764233
2044871-06-7 | methyl 2-(1-chloroethyl)-1,3-oxazole-4-carboxylate | AA01C5AM | MFCD30476088
52098-73-4 | N-ethyl-1,2,3,4-thiatriazol-5-amine | AA01C5F6 | MFCD19216993